Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Nature Communications
|
March 4, 2025
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies
Maurizio Callari, Matteo Dugo, Marco Barreca, et al.
The Journal of Pathology
|
October 25, 2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors
Ilenia Segatto, Maria Chiara Mattevi, Gian Luca Rampioni Vinciguerra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2023
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response
Carlo Bosi, Áron Bartha, Barbara Galbardi, et al.
BMC Genomics
|
April 22, 2009
A transcriptional sketch of a primary human breast cancer by 454 deep sequencing
Alessandro Guffanti, Michele Iacono, Paride Pelucchi, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2024
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
Brenno Pastò, Giulia Buzzatti, Clorinda Schettino, et al.
NPJ Precision Oncology
|
June 15, 2026
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy
Giulia Notini, Barbara Galbardi, Giulia Viale, et al.
Molecular Oncology
|
April 15, 2025
A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival
Emma J Beddowes, Mario Ortega Duran, Solon Karapanagiotis, et al.
International Journal of Molecular Sciences
|
May 28, 2022
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study
Laura Mannarino, Lara Paracchini, Federica Pezzuto, et al.
Nature Communications
|
April 1, 2021
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
Dimitra Georgopoulou, Maurizio Callari, Oscar M Rueda, et al.
Nature
|
March 15, 2019
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Oscar M Rueda, Stephen-John Sammut, Jose A Seoane, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Nature Communications
|
March 4, 2025
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies
Maurizio Callari, Matteo Dugo, Marco Barreca, et al.
The Journal of Pathology
|
October 25, 2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors
Ilenia Segatto, Maria Chiara Mattevi, Gian Luca Rampioni Vinciguerra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2023
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response
Carlo Bosi, Áron Bartha, Barbara Galbardi, et al.
BMC Genomics
|
April 22, 2009
A transcriptional sketch of a primary human breast cancer by 454 deep sequencing
Alessandro Guffanti, Michele Iacono, Paride Pelucchi, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2024
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
Brenno Pastò, Giulia Buzzatti, Clorinda Schettino, et al.
NPJ Precision Oncology
|
June 15, 2026
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy
Giulia Notini, Barbara Galbardi, Giulia Viale, et al.
Molecular Oncology
|
April 15, 2025
A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival
Emma J Beddowes, Mario Ortega Duran, Solon Karapanagiotis, et al.
International Journal of Molecular Sciences
|
May 28, 2022
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study
Laura Mannarino, Lara Paracchini, Federica Pezzuto, et al.
Nature Communications
|
April 1, 2021
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
Dimitra Georgopoulou, Maurizio Callari, Oscar M Rueda, et al.
Nature
|
March 15, 2019
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Oscar M Rueda, Stephen-John Sammut, Jose A Seoane, et al.
Page
of 7